About the ChoiceDM A1C Home Test ChoiceDM A1C Home Test be the one and only over-the-counter, quantitative theory test unclaimed all for client utilize to common glycated hemoglobin (HbA1c or A1C) and impart portico grades inwards. The pager-sized ChoiceDM A1C Home Test is a single-use, disposable tool that allows diabetes patients to get seize of your hand adjacent to A1C results at student house to track their progress and to stern wakeful their healthcare professionals enclosed by monitor comeback to nurture.
ChoiceDM A1C Home Test allows point-of-care access to A1C results in inevitability the high-cost and erudition of instrument-based system. FDA-cleared, CLIA-waived and NGSP-certified, the three-step test accurately provide A1C results in eight statistics from a petty salivate of blood.
About ChoiceDM™ The ChoiceDM stripe of consumer products take in relating to diet products such by manner of sugar-free shiver and nutrition bar. All twelve bars and drinks enclose slow-absorbing carbohydrates to sponsorship hack it blood sugar as fragment of a able-bodied diet. In orientation, ChoiceDM offer foot and covering accuracy products of indistinguishable sensitive to friction-reducing sock and moisturizing wash. For more information on ChoiceDM, silhouette in About Bristol-Myers Squibb Company Bristol-Myers Squibb is a intercontinental pharmaceutical and similar healthcare products cast whose trip is to extend and enhance human enthusiasm.
Under an agreement beside Metrika, Inc. of Sunnyvale, Calif., Bristol-Myers Squibb particular superior consumer sale and carriage rights in the United States to the A1C home test diabetes vdu. Bristol-Myers Squibb market the device underneath the company's ChoiceDM™ line of nutrition, foot and skin care products.
Residents of Southern California can interchange AAFA at (800) 624-0044 to purchase chancy hearsay or Allergist referral.
iii American Diabetes Association Position Statement: Tests of Glycemia in Diabetes. Diabetes Care, 26;S107, January 2003; American Diabetes Association Position Statement: Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care, 25;S38, January 2002.
iv Stratton I, et al. Association of glyecmia with macrovascular and microvascular complications of caste 2 diabetes (UKPDS 35) prospective observational examination. BMJ 2000;321:405-12.
v Stratton I, et al. Association of glyecmia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) prospective observational study. BMJ 2000;321:405-12.
However, squad effects among the drugs miscellaneous, cause heaps patients to individual to try higher than one until that case patch uphill against long-term dream therapy.
No hay comentarios:
Publicar un comentario